BUSINESS: Financial http://www.visionmonday.com/rss/business/financial/ Mon, 18 Mar 2024 23:57:50 -0400 Safilo Group Reports Full Year 2023 Financial Results http://www.visionmonday.com/business/article/safilo-group-reports-full-year-2023-financial-results/ Fri, 15 Mar 2024 00:30:00 -0400 PADUA, Italy—The board of directors of <a href="https://www.safilogroup.com/en" target="_blank">Safilo Group S.p.A.</a> (SFLG.MI) has approved the company’s consolidated financial statements for the year ended December 31, 2023, and examined the separate financial statements for the year ended December 31, 2023. http://www.visionmonday.com/business/article/safilo-group-reports-full-year-2023-financial-results/ RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results http://www.visionmonday.com/business/article/rxsight-inc-reports-fourth-quarter-and-full-year-2023-financial-results/ Mon, 04 Mar 2024 00:15:00 -0400 ALISO VIEJO, Calif.—<a href="https://rxsight.com/" target="_blank">RxSight, Inc.</a>, an ophthalmic medical device company dedicated to providing customized vision to patients following cataract surgery, reported financial results for the three months and full year ending Dec. 31, 2023. http://www.visionmonday.com/business/article/rxsight-inc-reports-fourth-quarter-and-full-year-2023-financial-results/ CooperCompanies Reports Q1 2024 Revenue Increase, Raises Fiscal Year Guidance for 2024 http://www.visionmonday.com/business/article/coopercompanies-reports-q1-2024-revenue-increase-raises-fiscal-year-guidance-for-2024/ Fri, 01 Mar 2024 00:24:00 -0400 SAN RAMON, Calif.—<a href="https://www.coopercos.com/" target="_blank">CooperCompanies</a> (Nasdaq: COO)  yesterday announced the financial results for its fiscal first quarter ended Jan. 31, 2024. Overall, revenue increased 9 percent year-over-year to $931.6 million; CooperVision (CVI) revenue was up 7 percent to $621.5 million, and CooperSurgical (CSI) revenue was up 12 percent to $310.1 million. Al White, Cooper’s president and CEO, said, “We're off to an outstanding start this fiscal year. We delivered record quarterly revenues in Q1 with contact lenses growing solidly and fertility posting its 13th consecutive quarter of double-digit organic growth. http://www.visionmonday.com/business/article/coopercompanies-reports-q1-2024-revenue-increase-raises-fiscal-year-guidance-for-2024/ Alcon Reports Sales Growth in Q4 and Full-Year 2023 http://www.visionmonday.com/business/article/alcon-reports-sales-growth-in-q4-and-fullyear-2023/ Thu, 29 Feb 2024 00:27:00 -0400 GENEVA—<a href="https://www.alcon.com/" target="_blank">Alcon</a> (SIX/NYSE:ALC), a global leader in eyecare, reported its financial results for the three and 12 months ending Dec. 31, 2023. For the fourth quarter of 2023, sales were $2.3 billion, an increase of 8 percent on a reported basis and 10 percent on a constant currency basis, as compared with the same quarter of the previous year. Sales for the full year 2023 were $9.4 billion, an increase of 8 percent on a reported basis and 10 percent on a constant currency basis, compared with the full year 2022. http://www.visionmonday.com/business/article/alcon-reports-sales-growth-in-q4-and-fullyear-2023/ Warby Parker Announces Fourth Quarter and Full Year 2023 Results http://www.visionmonday.com/business/article/warby-parker-announces-fourth-quarter-and-full-year-2023-results/ Thu, 29 Feb 2024 00:24:00 -0400 NEW YORK—<a href="https://www.warbyparker.com/" target="_blank">Warby Parker Inc.</a> (NYSE: WRBY), a direct-to-consumer lifestyle brand focused on vision for all, announced financial results for the fourth quarter and full year ending Dec. 31, 2023. Fourth quarter net revenue increased $15.4 million, or 10.5 percent, to $161.9 million compared with fourth quarter 2022. http://www.visionmonday.com/business/article/warby-parker-announces-fourth-quarter-and-full-year-2023-results/ National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2023 Financial Results http://www.visionmonday.com/business/article/national-vision-holdings-inc-reports-fourth-quarter-and-fiscal-2023-financial-results/ Wed, 28 Feb 2024 00:24:00 -0400 DULUTH, Ga.—<a href="https://www.nationalvision.com/" target="_blank">National Vision Holdings, Inc.</a> (NASDAQ: EYE), one of the largest optical retail companies in the U.S., reported its financial results for the fourth quarter and fiscal year ending Dec. 30, 2023, and provided its outlook for fiscal 2024. Net revenue increased 8.0 percent to $506.4 million compared with the fourth quarter of 2022, primarily due to an increase in adjusted comparable store sales growth and growth from new stores sales, partially offset by closed stores. http://www.visionmonday.com/business/article/national-vision-holdings-inc-reports-fourth-quarter-and-fiscal-2023-financial-results/ STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results http://www.visionmonday.com/business/article/staar-surgical-reports-fourth-quarter-and-fiscal-year-2023-results/ Tue, 27 Feb 2024 00:18:00 -0400 LAKE FOREST, Calif.—<a href="https://www.staar.com/" target="_blank">STAAR Surgical Company</a>, a leading developer, manufacturer and marketer of the EVO family of implantable collamer lenses for myopia, astigmatism and presbyopia, reported financial results for the fourth quarter and fiscal year ending Dec. 29, 2023. http://www.visionmonday.com/business/article/staar-surgical-reports-fourth-quarter-and-fiscal-year-2023-results/ Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results http://www.visionmonday.com/business/article/glaukos-announces-fourth-quarter-and-full-year-2023-financial-results/ Fri, 23 Feb 2024 00:21:00 -0400 ALISO VIEJO, Calif.—<a href="https://www.glaukos.com/" target="_blank">Glaukos Corporation</a>, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced financial results for the fourth quarter and full year ending Dec. 31, 2023. http://www.visionmonday.com/business/article/glaukos-announces-fourth-quarter-and-full-year-2023-financial-results/ Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance http://www.visionmonday.com/business/article/bausch-lomb-announces-fourthquarter-and-fullyear-2023-results-and-provides-2024-guidance/ Thu, 22 Feb 2024 00:24:00 -0400 VAUGHAN, Ontartio—<a href="https://www.bausch.com/" target="_blank">Bausch + Lomb Corporation</a> (NYSE/TSX: BLCO), a leading global eye health company, announced its fourth-quarter and full-year 2023 financial results. Total reported revenue was $1.173 billion for the fourth quarter of 2023, as compared to $996 million in the fourth quarter of 2022, an increase of $177 million, or 18 percent. Total reported revenue was $4.146 billion for the full year of 2023, as compared to $3.768 billion in the full year of 2022, an increase of $378 million, or 10 percent. http://www.visionmonday.com/business/article/bausch-lomb-announces-fourthquarter-and-fullyear-2023-results-and-provides-2024-guidance/ Vision Integrated Partners Completes Refinancing http://www.visionmonday.com/business/article/vision-integrated-partners-completes-refinancing/ Thu, 22 Feb 2024 00:18:00 -0400 ST. LOUIS—<a href="https://vipus.com/" target="_blank">Vision Integrated Partners</a> (VIP), a leader in providing ophthalmology practice and ambulatory surgery center management services, has successfully completed a recapitalization. http://www.visionmonday.com/business/article/vision-integrated-partners-completes-refinancing/